Financial Times
AbbVie closes in on nearly $11bn deal for biotech Apogee Therapeutics
Buyout comes amid an uptick in biotech dealmaking as Big Pharma seeks to bolster its drug pipelines
View original source — Financial Times ↗
Related stories
Financial Times
HealthJun 9, 2026 · 1 min
GSK in talks to buy cancer biotech Nuvalent for more than $9bn
Financial Times
CNBC
HealthJun 9, 2026 · 1 min
GSK in talks to acquire Nuvalent for more than $9 billion in biggest deal in over a decade: FT
CNBC
Bloomberg
HealthJun 9, 2026 · 1 min
GSK Agrees to Buy Nuvalent for $10.6 Billion
Bloomberg
South China Morning Post
HealthJun 21, 2026 · 1 min
Cross-border biotech deals grow more complex as US targets China investment links
South China Morning Post